NRD204CN

Phase III Study of NRD101: A confirmatory study of NRD101 in patients with knee osteoarthritis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223476

Enrollment

260

Registered

2017-03-10

Start date

2017-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

investigational material(s) Generic name etc : NRD101 INN of investigational material : - Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigatio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with knee osteoarthritis based on the American College of Rheumatology (ACR) Clinical Classification Criteria. (2) The study knee is classified as Kellgren-Lawrence Grade 2 or Grade 3.

Exclusion criteria

Exclusion criteria: (1) Patients diagnosed with secondary knee osteoarthritis. (2) Patients with other diseases/disorders causing functional impairment of the knee.

Design outcomes

Primary

Measure	Time frame
efficacy Variation of score	—

Secondary

Measure	Time frame
efficacy Transition in score	—

Countries

Asia except Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026